Cell Source Inc (CLCS)

Currency in USD
0.400
+0.020(+5.26%)
Closed·
CLCS Scorecard
Full Analysis
Stock generally trades with high price volatility
CLCS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.4000.470
52 wk Range
0.1390.840
Key Statistics
Prev. Close
0.38
Open
0.435
Day's Range
0.4-0.47
52 wk Range
0.139-0.84
Volume
5K
Average Volume (3m)
9.85K
1-Year Change
14.29%
Book Value / Share
-0.44
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CLCS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Cell Source Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral

Cell Source Inc Company Profile

Cell Source, Inc., a biotechnology company, engages in developing cell therapy treatments based on the management of immune tolerance. Its lead product is the Veto Cell immune system management technology, which is an immune tolerance biotechnology that enables the selective blocking of immune responses. The company’s Veto Cell technology is used in various applications, including treatment of lymphoma, leukemia, and multiple myeloma through facilitation of the stem cell transplantation acceptance, as well as treatment of end stage kidney disease; other non-malignant organ diseases through organ transplantation; and various cancers and non-malignant diseases. Cell Source, Inc. is headquartered in New York, New York.

Compare CLCS to Peers and Sector

Metrics to compare
CLCS
Peers
Sector
Relationship
P/E Ratio
−3.0x−2.0x−0.5x
PEG Ratio
−0.240.000.00
Price/Book
−1.0x2.3x2.6x
Price / LTM Sales
-166.1x3.2x
Upside (Analyst Target)
-56.7%45.7%
Fair Value Upside
Unlock−2.2%8.6%Unlock

Earnings

Latest Release
Nov 14, 2024
EPS / Forecast
-0.04 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

CLCS Income Statement

FAQ

What Stock Exchange Does Cell Source Inc Trade On?

Cell Source Inc is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Cell Source Inc?

The stock symbol for Cell Source Inc is "CLCS."

What Is the Cell Source Inc Market Cap?

As of today, Cell Source Inc market cap is 19.77M.

What Is Cell Source Inc's Earnings Per Share (TTM)?

The Cell Source Inc EPS (TTM) is -0.16.

From a Technical Analysis Perspective, Is CLCS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Cell Source Inc Stock Split?

Cell Source Inc has split 0 times.

How Many Employees Does Cell Source Inc Have?

Cell Source Inc has 1 employees.

What is the current trading status of Cell Source Inc (CLCS)?

As of 02 Aug 2025, Cell Source Inc (CLCS) is trading at a price of 0.40, with a previous close of 0.38. The stock has fluctuated within a day range of 0.40 to 0.47, while its 52-week range spans from 0.14 to 0.84.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.